NCT06660342View on ClinicalTrials.gov

A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring

RecruitingOBSERVATIONAL
Enrollment

728

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

September 30, 2034

Study Completion Date

September 30, 2034

Conditions
Erosive EsophagitisHeartburnSymptomatic Non-erosive Gastroesophageal Reflux DiseaseHelicobacter Pylori Infection
Interventions
DRUG

Vonoprazan

Oral tablet.

Trial Locations (1)

28401

RECRUITING

PPD, Wilmington

Sponsors
All Listed Sponsors
lead

Phathom Pharmaceuticals, Inc.

INDUSTRY